CTLA-4 inhibitors

CTLA-4 inhibitors are a type of cancer immunotherapy that help the immune system recognize and attack cancer cells. They work by blocking a protein called CTLA-4, which usually acts as a brake on immune responses. By inhibiting this protein, these drugs enhance the immune system's ability to target tumors. CTLA-4 inhibitors have shown effectiveness in treating certain cancers, like melanoma and lung cancer, and are often used in combination with other treatments to improve outcomes for patients. Overall, they represent a promising approach in the fight against cancer.